Terms: = Lymphoma AND HIF1A, Q16665, 3091, ENSG00000100644, MOP1, HIF1-ALPHA, PASD8, HIF-1alpha AND Clinical Outcome
4 results:
1. Increased expression of hypoxia-inducible factor-1 alpha and its impact on transcriptional changes and prognosis in malignant tumours of the ocular adnexa.
Lange CAK; Lehnert P; Boneva SK; Zhang P; Ludwig F; Boeker M; Hoffmeier K; Horres R; Schlunck G; Reinhard T; Böhringer D; Auw-Haedrich C
Eye (Lond); 2018 Nov; 32(11):1772-1782. PubMed ID: 30065361
[TBL] [Abstract] [Full Text] [Related]
2. Glycolytic inhibitor 2-deoxy-d-glucose suppresses cell proliferation and enhances methylprednisolone sensitivity in non-Hodgkin lymphoma cells through down-regulation of HIF-1α and c-MYC.
Pang YY; Wang T; Chen FY; Wu YL; Shao X; Xiao F; Huang HH; Zhong H; Zhong JH
Leuk Lymphoma; 2015 Jun; 56(6):1821-30. PubMed ID: 25219592
[TBL] [Abstract] [Full Text] [Related]
3. Catabolic cancer-associated fibroblasts transfer energy and biomass to anabolic cancer cells, fueling tumor growth.
Martinez-Outschoorn UE; Lisanti MP; Sotgia F
Semin Cancer Biol; 2014 Apr; 25():47-60. PubMed ID: 24486645
[TBL] [Abstract] [Full Text] [Related]
4. BCL2 predicts survival in germinal center B-cell-like diffuse large B-cell lymphoma treated with CHOP-like therapy and rituximab.
Iqbal J; Meyer PN; Smith LM; Johnson NA; Vose JM; Greiner TC; Connors JM; Staudt LM; Rimsza L; Jaffe E; Rosenwald A; Ott G; Delabie J; Campo E; Braziel RM; Cook JR; Tubbs RR; Gascoyne RD; Armitage JO; Weisenburger DD; Chan WC
Clin Cancer Res; 2011 Dec; 17(24):7785-95. PubMed ID: 21933893
[TBL] [Abstract] [Full Text] [Related]
